September 4, 2015
Doctor's attempt to bring lower-price diabetes drug to market thwarted
Davidson cited a recent paper in the Journal of the American Medical Assn. showing that prices of both generic and patented insulins have jumped more than 500% since 2001. The cost of a vial of one of the most commonly used fast-acting insulins, Humalog, soared to $234 this year from $35 in 2001, the journal said.
Oops. Did I really say that drug companies need our support? My bad. I meant to say that drug companies need our life support! Huge difference. Sorry about that.
Do you know what else I meant to say? Well, it rhymes with fun of a witch! Bass wholes! Druther buckers! Whoosh rags! Sigh.
AIA: "Architecture firm billings retreat further in March"; Multi-family
Billings Decline for 20th Consecutive Month
-
Note: This index is a leading indicator primarily for new Commercial Real
Estate (CRE) investment.
From the AIA: ABI March 2024: Architecture firm billings...
2 hours ago
No comments:
Post a Comment